Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

2 Biotechs That Plunged More Than 20% Yesterday

  • Post author:Sam
  • Post published:February 5, 2018
  • Post category:BioPharma

After yesterday's big plunge in the stock market, and today with the Dow Jones Industrial Average dropping more than 500 points after opening, but mostly recovering, volatility appears to be…

Continue Reading2 Biotechs That Plunged More Than 20% Yesterday

Why This Biotech CEO Injected Himself With a DIY Herpes Vaccine on Facebook Live

  • Post author:Sam
  • Post published:February 5, 2018
  • Post category:BioPharma

The 28-year-old CEO of Ascendance Biomedical removed his trousers and injected himself at the BDYHAX conference in Texas. Source: BioSpace

Continue ReadingWhy This Biotech CEO Injected Himself With a DIY Herpes Vaccine on Facebook Live

Two Drugmakers Compete for Sanofi's $2.4B Generics Biz

  • Post author:Sam
  • Post published:February 5, 2018
  • Post category:BioPharma

According to sources reported by Reuters, potential buyers have been winnowed down to two pharma companies, three private equity funds, and a consortium of buyers. Source: BioSpace

Continue ReadingTwo Drugmakers Compete for Sanofi's $2.4B Generics Biz

FDA Calls Bay Area Zogenix's Dravet Syndrome Drug a Breakthrough

  • Post author:Sam
  • Post published:February 5, 2018
  • Post category:BioPharma

Zogenix’s first global Phase 3 trial of ZX008, met the primary efficacy endpoint, as well as all prespecified key secondary efficacy endpoints. Source: BioSpace

Continue ReadingFDA Calls Bay Area Zogenix's Dravet Syndrome Drug a Breakthrough

Allergan Shows Off Phase III Migraine Data

  • Post author:Sam
  • Post published:February 5, 2018
  • Post category:BioPharma

The ACHIEVE I study included 1327 U.S. adult patients. Source: BioSpace

Continue ReadingAllergan Shows Off Phase III Migraine Data

Genentech's Tecentriq Impresses Again in Late-Stage Kidney Cancer Trial

  • Post author:Sam
  • Post published:February 5, 2018
  • Post category:BioPharma

Genentech said the Phase III combination therapy improved progression-free survival by 26 percent in mRCC patients whose disease expressed a PD-L1 protein. Source: BioSpace

Continue ReadingGenentech's Tecentriq Impresses Again in Late-Stage Kidney Cancer Trial

Meet the UK Biotech Developing a Vaccine for Every Type of Flu

  • Post author:Sam
  • Post published:February 5, 2018
  • Post category:BioPharma

The company says the vaccine takes a novel approach. Source: BioSpace

Continue ReadingMeet the UK Biotech Developing a Vaccine for Every Type of Flu

Celgene's Multiple Myeloma Triplet Succeeds in Key Phase III Trial

  • Post author:Sam
  • Post published:February 5, 2018
  • Post category:BioPharma

The international clinical study, OPTIMISMM, achieved its primary endpoint. Source: BioSpace

Continue ReadingCelgene's Multiple Myeloma Triplet Succeeds in Key Phase III Trial

Nexgen Pharma Cited for GMP Violations

  • Post author:Sam
  • Post published:February 5, 2018
  • Post category:Drug Industry Daily

The FDA hit Nexgen Pharma with a Form 483 after an inspection of its Irvine, California facility revealed procedural and documentation issues. Source: Drug Industry Daily

Continue ReadingNexgen Pharma Cited for GMP Violations

CDER Denies Fourth United Therapeutics Petition on ANDAs Referencing Tyvaso

  • Post author:Sam
  • Post published:February 5, 2018
  • Post category:Drug Industry Daily

CDER denied a fourth petition from United Therapeutics calling on the center to impose additional conditions before approving ANDAs for combination products that reference its pulmonary arterial hypertension drug Tyvaso…

Continue ReadingCDER Denies Fourth United Therapeutics Petition on ANDAs Referencing Tyvaso
  • Go to the previous page
  • 1
  • …
  • 176
  • 177
  • 178
  • 179
  • 180
  • 181
  • 182
  • …
  • 610
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.